Advertisement
Canada markets closed
  • S&P/TSX

    21,885.38
    +11.66 (+0.05%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • CAD/USD

    0.7323
    +0.0025 (+0.35%)
     
  • CRUDE OIL

    83.78
    +0.97 (+1.17%)
     
  • Bitcoin CAD

    88,378.94
    +1,110.62 (+1.27%)
     
  • CMC Crypto 200

    1,394.91
    +12.34 (+0.89%)
     
  • GOLD FUTURES

    2,344.40
    +6.00 (+0.26%)
     
  • RUSSELL 2000

    1,981.12
    -14.31 (-0.72%)
     
  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     
  • NASDAQ

    15,611.76
    -100.99 (-0.64%)
     
  • VOLATILITY

    15.37
    -0.60 (-3.76%)
     
  • FTSE

    8,078.86
    +38.48 (+0.48%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • CAD/EUR

    0.6823
    +0.0004 (+0.06%)
     

Company News for May 12, 2023

  • Shares of CyberArk Software Ltd. (CYBR) gained 3.9% after the company reported first-quarter 2023 loss of $0.17 per share, narrower than the Zacks Consensus Estimate of a loss of $0.26 per share.

  • Geron Corporation’s (GERN) shares rose 2.5% after the company reported first-quarter 2023 loss of $0.07 per share, narrower the Zacks Consensus Estimate of a loss of $0.09 per share.

  • Shares of Tapestry, Inc. (TPR) jumped 8.3% after the company reported third-quarter fiscal 2023 earnings of $0.78 per share, beating the Zacks Consensus Estimate of $0.59 per share.

  • Dillard's, Inc.’s (DDS) shares increased 0.2% after the company reported first-quarter 2023 earnings of $11.77 per share, outpacing the Zacks Consensus Estimate of $9.07 per share.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Dillard's, Inc. (DDS) : Free Stock Analysis Report

Geron Corporation (GERN) : Free Stock Analysis Report

CyberArk Software Ltd. (CYBR) : Free Stock Analysis Report

Tapestry, Inc. (TPR) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research